Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Fife, WA – FDA Inspections
Inspection records and compliance data for Linde Inc in Fife, Washington. 1 FDA inspection on record, last inspected June 20, 2012. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Fife, Washington, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 20, 2012.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 20, 2012 | NAI | Human Drugs · Drug Quality Assurance | 786892 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3019570
Address
2902 20th St E, Fife, Washington 98424, United States
Country
United States
ID: 8acfd764-d595-4cd3-a673-a78ebe68d104